Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;24(3):1-9.
doi: 10.1117/1.JBO.24.3.035006.

Validation of combined Monte Carlo and photokinetic simulations for the outcome correlation analysis of benzoporphyrin derivative-mediated photodynamic therapy on mice

Affiliations

Validation of combined Monte Carlo and photokinetic simulations for the outcome correlation analysis of benzoporphyrin derivative-mediated photodynamic therapy on mice

Karl W Beeson et al. J Biomed Opt. 2019 Mar.

Abstract

We compare previously reported benzoporphyrin derivative (BPD)-mediated photodynamic therapy (PDT) results for reactive singlet oxygen concentration (also called singlet oxygen dose) on mice with simulations using a computational device, Dosie™, that calculates light transport and photokinetics for PDT in near real-time. The two sets of results are consistent and validate the use of the device in PDT treatment planning to predict BPD-mediated PDT outcomes in mice animal studies based on singlet oxygen dose, which showed a much better correlation with the cure index than the conventional light dose.

Keywords: medical device; photodynamic therapy; solid cancer therapy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Schematic diagram for Dosie™ integrated computer and software computational device. The computer includes both a GPU and a multicore CPU. The software first performs a MC simulation of light transport that is followed by a PK simulation.
Fig. 2
Fig. 2
Dosie™ GUI screenshots: MC fluence rate results using 0.50-mm voxels for an incident fluence rate of 50  mW/cm2. Volume rendering is done to visualize 3-D fluence rate map in the upper left view, whereas other views show three 2-D cross-sections (slices) of the map—sagittal, coronal, and transverse views.
Fig. 3
Fig. 3
YZ slice of Dosie™’s MC fluence rate results using 0.50-mm voxels through the center of the target volume for an incident fluence rate of 50  mW/cm2.
Fig. 4
Fig. 4
The ratio (fluence rate in tissue)/(fluence rate in air) versus depth in tissue that compares an analytical fit to Dosie™’s MC results.
Fig. 5
Fig. 5
YZ slice of Dosie™’s PK [O12]rx results through the center of the target volume shown for an incident fluence rate of 50  mW/cm2 for 600 s and for 0.50-mm voxels.
Fig. 6
Fig. 6
Comparison of Dosie™’s PK results to Penn results for 1-mm, 0.50-mm, and 0.25-mm voxels.
Fig. 7
Fig. 7
Penn experimental cure index (CI) data from Ref.  versus Dosie™ calculated singlet oxygen dose, [O12]rx, at 3 mm below the target surface for 0.50-mm grid. The CI error bars and the expression for the solid line, CI=1.08/(1+3490×exp(8.301×[O12]rx)) are from Ref. .
Fig. 8
Fig. 8
Cure index versus conventional light dose (in-air incident fluence on the target surface). Data taken from Ref. .

Similar articles

Cited by

References

    1. Huang Z., “A review of progress in clinical photodynamic therapy,” Technol. Cancer Res. Treat. 4, 283–293 (2005).10.1177/153303460500400308 - DOI - PMC - PubMed
    1. Wilson B. C., Patterson M. S., “The physics, biophysics, and technology of photodynamic therapy,” Phys. Med. Biol. 53, R61–R109 (2008).PHMBA710.1088/0031-9155/53/9/R01 - DOI - PubMed
    1. Zhu T. C., Finlay J. C., “The role of photodynamic therapy (PDT) physics,” Med. Phys. 35, 3127–3136 (2008).MPHYA610.1118/1.2937440 - DOI - PMC - PubMed
    1. Agostinis P., et al. , “Photodynamic therapy of cancer: an update,” CA Cancer J. Clin. 61, 250–281 (2011).CAMCAM10.3322/caac.v61:4 - DOI - PMC - PubMed
    1. Simone C. B., et al. , “Photodynamic therapy for the treatment of non-small cell lung cancer,” J. Thorac. Dis. 4, 63–75 (2012).10.3978/j.issn.2072-1439.2011.11.05 - DOI - PMC - PubMed

Publication types